Abstract
Trace elements and lipid peroxidation in 26 patients with chronic renal failure treated with hemodialysis and 25 healthy subjects were observed. Both plasma and erythrocyte trace elements and plasma malon dialdehyde (MDA) were examined immediately before and after hemodialysis. Increased levels of plasma Cu, MDA, and erythrocyte Pb, Mn, Zn, and a significantly decreased plasma Se, Zn and erythrocyte Se were found in patients before hemodialysis. After a single hemodialysis, erythrocyte Mn, Cu, Zn, and plasma Cu, Al, and MDA were significantly increased whereas both plasma and erythrocyte Se were lower in patients than in healthy subjects. The level of MDA was not significantly changed during the single hemodialysis. Both plasma and erythrocyte Zn levels and plasma Cu and Al were significantly higher after hemodialysis than before hemodialysis. In conclusion, levels of trace elements are altered by hemodialysis, which may increase patient susceptibility to lipid peroxidation in uremia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. F. Maher inReplacement of Renal Function by Dialysis, 3rd Ed., Kluwer, Dordrecht, pp. 996–1003 (1989).
K. M. Robert, K. G. Daryl, A. M. Peter, and W. R. Victor inHarper's Biochemistry, 21st Ed., Prentice-Hall, Englewood Cliffs, NJ, pp. 138–139 (1988).
M. T. Santos, J. Valles, J. Aznar, and J. Vilches,J. Clin. Pathol. 33, 973–976 (1980).
S. Humad, E. J. Zarling, and J. L. Skosey,Clin. Res.,33, 919A (1985).
I. Nishigake, M. Hagihara, and H. Tsunekawa, M. Maseki, and K. Yagi,Biochem. Med. 25, 373–378 (1981).
J. Aznar, M. T. Santos, J. Valles, and J. Sala,J. Clin. Pathol.,36, 712–715 (1984).
T. Suematsu and H. Abe inLipid Peroxides in Medicine and Biology, Yagi, K., ed., Academic, New York, pp. 285–293 (1982).
B. Halliwell and J. M. C. Gutteridge,Biochem. J. 219, 1–14 (1984).
B. Halliwell,Med. Biol. 62, 71–77 (1984).
F. W. Sunderman, Jr.,Acta. Pharmacol. Toxicol. 59, (Suppl 7), 248–255 (1986).
J. A. Knight, R. K. Pieper, S. E. Smith, and H. H. Crockett,Ann. Clin. Lab. Sci. 18, 374–377 (1988).
A. Wendel, S. Feurstein, and K. H. Konz,Biochem. Pharmacol. 28, 2051–2055 (1979).
R. F. Burk and J. M. Lane,Toxicol. Appl. Pharmacol. 50, 467–478 (1979).
S. Yasaka, I. Ohya, J. Matsumoto, T. Shiramizu, and Y. Sasaguri,Arch. Intern. Med. 141, 1169–1171 (1981).
M. Uysal, H. Bulur, S. Erdine-Demirelli, and C. Demiroglu,Drug. Alcohol. Depend. 18, 385–388 (1986).
J. A. Knight and R. P. Voorhees,Ann. Clin. Lab. Sci. 20, 347–352 (1990).
S-H-Y Wong, J. A. Knight, S. M. Hopfer, O. Zaharria, C. N. Leach, Jr., and F. W. Sunderman,J. Clin. Chem. 33, 214–220 (1987).
W. R. Smythe, A. C. Alfrey, R. C. Holman, and W. J. Schorr,Kidney Int. 12, 361 (1982).
J. J. Dougherty and W. G. Hoekstra,Proc. Soc. Exp. Biol. Med. 169, 201–208 (1982).
H. J. Fukino, M. Hirai, Y. M. Hseuh, and Y. Yamane,Toxicol. Appl. Pharmacol. 73, 395–401 (1984).
O. A. Levander, V. C. Morris, and R. J. Ferretti,J. Nutr. 107, 363–372 (1977).
N. Sugawara and C. Sugawara,J. Appl. Biochem. 6, 199–204 (1984).
M. J. Richard, J. Armand, C. Jurkovitz, T. Hachache, H. Meftahi, F. Laporte, M. Foret, A. Farier, and D. Cordonnier,Nephron. 57, 10–15 (1991).
P. R. Craddock, J. Fehr, and A. P. Dalmasso,J. Clin. Invest. 59, 879–888 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lin, T.H., Chen, J.G., Liaw, J.M. et al. Trace elements and lipid peroxidation in uremic patients on hemodialysis. Biol Trace Elem Res 51, 277–283 (1996). https://doi.org/10.1007/BF02784082
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02784082